Salute e Benessere

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for…

Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationDesignation earned for a one-time intravitreal gene therapy with the potential to eliminate treatment burden for people living with neovascular age-related macular degenerationNeovascular or “wet” age-related macular degeneration can lead to significant vision loss and affects more than one million people in the USParis, September 11, 2025. The US Food and Drug Administration...
Nasdaq GlobeNewswire
11/09/2025

HaemaLogiX wins "Most Promising CAR-T Pipeline in APAC" at the Asia Pacific CGT¹…

"This award is wonderful recognition of not just our science, but also the dedication and vision that drives our work," said Rosanne Dunn, Founder and Chief Scientific Officer of HaemaLogiX. "We're honoured to be recognised in such exceptional company - a field of the region's top innovators - all striving to redefine what's possible in CAR T-cell therapy. We're more determined than ever to advance transformative therapies, particularly for multiple myeloma – the world's second…
PR Newswire
11/09/2025

Bioptimus Assembles Elite Scientific Advisory Board to Build Next-Gen AI Models…

Eight internationally renowned experts join Bioptimus to pioneer large-scale foundation models that will transform science and medicine PARIS, Sept.11, 2025(GLOBE NEWSWIRE) -- Bioptimus, the pioneering start-up building the world’s first universal foundation model for biology, today announced the formation of its Scientific Advisory Board (SAB), bringing together some of the most influential minds at the intersection of biology, artificial intelligence, and medicine.The SAB will...
Nasdaq GlobeNewswire
11/09/2025

TROP2-Targeted Antibody-Drug Conjugates Set to Transform NSCLC Treatment Market…

TROP2 ADCs in NSCLC Market Summary TROP2 ADCs in NSCLC Market Summary Discover which indication is expected to grab the major TROP2 ADCs in NSCLC market share @TROP2 ADCs in NSCLC Market Report Key Factors Driving the Growth of the TROP2 ADCs in NSCLC Market High Expression of TROP2 in NSCLC TROP2 is overexpressed in a significant proportion of NSCLC cases, including up to 64% of adenocarcinomas and 75% of squamous cell carcinomas. This widespread expression makes...
PR Newswire
10/09/2025

Endo Presents Plantar Fibromatosis and Plantar Fasciitis Data at the American…

"We are pleased to share information with the healthcare community on these important data to expand medical knowledge of these painful conditions," said James Tursi, M.D., Executive Vice President, Global Research & Development at Endo. "We are advancing a Phase 3 study aimed at exploring a potential nonsurgical treatment option for patients with PFI, further demonstrating our commitment to developing medicines that address challenging and burdensome conditions."…
PR Newswire
10/09/2025

Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its…

Lord Cameron joined Andy Saperstein, Co-President of Morgan Stanley, for the session entitled "A Conversation on Courage", an intimate dialogue exploring leadership, philanthropy, and their shared commitment to advancing progress in rare disease research and treatment. Lord Cameron joinedAndy Saperstein, Co-President of Morgan Stanley, for the session entitled "A Conversation on Courage", an intimate dialogue exploring leadership, philanthropy, and their shared commitment to…
PR Newswire
10/09/2025

Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta…

"Callisto's full walk-away automation for multiple sequencing approaches will allow us to establish Illumina whole-genome sequencing as a standard of care for all pediatric patients, while at the same time supporting the adoption of Oxford Nanopore sequencing for rapid diagnosis," said Bastiaan Tops, Head of Laboratory for Childhood Cancer Pathology at Prinses Máxima Center. "By simplifying complex sequencing workflows, Callisto frees our team to focus more of our time and…
PR Newswire
10/09/2025

IBA – TRANSPARENCY NOTIFICATION

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)Louvain-la-Neuve, Belgium, September 10, 2025 06:00 PM Summary of the notificationIBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification...
Nasdaq GlobeNewswire
10/09/2025

Tecan announces change of leadership in the Partnering Business division

Männedorf, Switzerland, September 10, 2025 –The Tecan Group (SIX Swiss Exchange: TECN) today announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering Business division and as a member of the Management Board since April 2020, will be leaving the Company to pursue other opportunities.The Board of Directors and CEO Monica Manotas thank Ralf Griebel for his strong engagement and important contributions in developing Tecan’s...
Nasdaq GlobeNewswire
10/09/2025

Idorsia shares new analyses of daridorexant for patients with insomnia at World…

Allschwil, Switzerland – September 10, 2025Idorsia Ltd (SIX: IDIA) shares new analyses of daridorexant for patients with insomnia and further characterizes insomnia disorder at World Sleep 2025, delivering on its ongoing commitment to further the science of sleep and insomnia. Antonio Olivieri, MD, Chief Medical Officer & Head of Global Medical Affairs, commented:“The World Sleep Society has once again delivered an outstanding event that advances the science of sleep and insomnia...
Nasdaq GlobeNewswire
10/09/2025

Three global institutions win million dollar prize for the 2025 António…

LCIF has enabled over 544 million people to access eye care. The programme has trained over 2.6 million eye health professionals and supported the construction of more than 1,700 eye care centres. It operates in 118 countries and has prevented severe vision loss in 30 million people. In 2024, the programme supported more than 10,500 cataract surgeries and 54,000 eye examinations. LCIFhas enabled over 544 million people to access eye care. The programme has trained over 2.6 million eye health...
PR Newswire
10/09/2025

Yifa Commercial Group to Present its Emerging Womenswear Brands at WHITE MILANO…

China's textile and fashion industry is entering a new phase characterized by agility, higher value, and design-driven innovation. Since its founding in Hangzhou in 2002, Yifa has remained committed to a strategy of original design and original manufacturing, building an end-to-end ecosystem that spans design, production, and global distribution. Through Yifa Exhibition, the group will introduce to the European market a selection of partners that demonstrate creative vitality, reliable quality…
PR Newswire
10/09/2025

Home Healthcare Market worth US$473.8 billion by 2030 with 8.9% CAGR |…

Browse in-depth TOC on 'Home Healthcare Market' Browse in-depth TOC on 'Home Healthcare Market' 295 - Tables 52 - Figures 349 - Pages By product segment,the home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. In 2024, therapeutic products held the largest share. This dominance is largely attributed to the increasing prevalence of chronic diseases such as diabetes, cancer, and kidney failure,...
PR Newswire
10/09/2025

Endoscope Reprocessing Market worth US$4.24 billion by 2030 with 9.4% CAGR |…

Browse in-depth TOC on "Endoscope Reprocessing Market" Browse in-depth TOC on "Endoscope Reprocessing Market" 332 - Tables 49 - Figures 297 - Pages By product,the endoscope reprocessing market is segmented into endoscope reprocessing equipment, endoscope reprocessing consumables, and endoscope tracking solutions. During the forecast period, the endoscope reprocessing consumables segment is expected to grow at a faster rate in the endoscope reprocessing market. This is...
PR Newswire
10/09/2025

Imaging Endpoints Announces Patent Application for AI Review Charter System

The new AIRC System addresses long-standing challenges in trial imaging design by assisting in the assimilation of data for intelligent, tailored modifications and/or clarifications to standard oncology criteria while ensuring alignment to current regulatory requirements of the FDA, EMA and other regulatory agencies across the globe. The new AIRC System addresses long-standing challenges in trial imaging design by assisting in the assimilation of data for intelligent, tailored modifications...
PR Newswire
10/09/2025

Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with…

Nanomi's LAI platform has demonstrated efficacy and safety in drug delivery. Its proprietary particle control technology creates uniform microspheres that deliver extended-release profiles from weeks to months, superior injectability through smaller needles, and consistent drug concentrations. The technology can provide lifecycle extension opportunities for products in development or on the market that would benefit from longer-acting formulations. Nanomi's LAI platform has demonstrated...
PR Newswire
10/09/2025

Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to…

Partnership brings Leap’s total investment to a quarter billion dollars – advancing toward a $1 billion goal to transform outcomes for women worldwide Women experience health issues differently, disproportionately, and uniquely – yet funding remains inadequate. Despite living longer, women spend an average of nine years of their lives in poor health, which is 25 percent more compared to men 1. Additionally, only 1 percent of global health research funding was allocated to women’s health...
Nasdaq GlobeNewswire
10/09/2025

Major shareholder announcement

Please read the full announcement in PDF Attachments Novozymes B 04 September 2025_Final2025_44_Major_Shareholders_Announcement
Nasdaq GlobeNewswire
10/09/2025

Invitation: Sobi's NASP and Uncontrolled Gout call and webcast

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call. The presentation can be followed livehere or afterwards on sobi.com. The slides will be made available onsobi.com before the conference call. To participate in the conference call, please use the following dial-in details: Sweden : +46 8 5051 0031 United Kingdom : +44 207 107 06 13United States : +1 631 570 56 13For other countries,...
PR Newswire
10/09/2025

Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United…

"We are extremely proud to bring our advanced HA technology to the United States through our collaboration with Waldencast and Obagi Medical," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. "This milestone reinforces our legacy of innovation and scientific excellence in aesthetic medicine. With more than 110 million syringes produced and a presence in over 80 markets, Croma is committed to delivering high-performing products that meet the expectations of…
PR Newswire
10/09/2025

SKF and Sieb & Meyer Announce Strategic Partnership for magnetic bearings

The collaboration will enhance SKF's offering by delivering an optimized package, combining SKF's high-speed electric motors on magnetic bearings with VFDs that are precisely tuned for performance, reliability, and energy efficiency. The collaboration will enhance SKF's offering by delivering an optimized package, combining SKF's high-speed electric motors on magnetic bearings with VFDs that are precisely tuned for performance, reliability, and energy efficiency. "By combining our…
PR Newswire
10/09/2025

Main owners strengthen their position in SciBase

Jan Poulsen, CEO at Life Science Invest Fund (LSIF), says: "With this additional investment we are happy to strengthen our ownership in SciBase as we believe SciBase is on track for an exciting journey in the coming years and is a very compelling investment case at this low valuation." Jan Poulsen, CEO at Life Science Invest Fund (LSIF), says: " With this additional investment we are happy to strengthen our ownership in SciBase as we believe SciBase is on track for an exciting…
PR Newswire
10/09/2025

Tata Elxsi Launches a Global Technology Centre for Medical Devices from Bayer in…

This collaboration leverages Tata Elxsi's healthcare engineering expertise and the strength of the Tata and India ecosystems—enabling access to advanced labs, regulatory partnerships, and specialised technology talent. This creates a scalable foundation for innovation and strengthens Bayer's ability to deliver radiology solutions across multiple geographies, including the US and EU. This collaboration leverages Tata Elxsi'shealthcare engineering expertiseand the strength of the Tata and...
PR Newswire
10/09/2025

Cumulus Neuroscience Appoints Robert Ballantine to Board of Directors

Photo - https://mma.prnewswire.com/media/2769272/Mr_Robert_Ballantine.jpgLogo - https://mma.prnewswire.com/media/2657658/5501171/Cumulus_Logo.jpg Photo -https://mma.prnewswire.com/media/2769272/Mr_Robert_Ballantine.jpgLogo -https://mma.prnewswire.com/media/2657658/5501171/Cumulus_Logo.jpg View original content: https://www.prnewswire.co.uk/news-releases/cumulus-neuroscience-appoints-robert-ballantine-to-board-of-directors-302551597.html
PR Newswire
10/09/2025
Altri  Comunicati